Endokrynologia Polska,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 19, 2024
Introduction:
Research
on
obesity,
which
results
from
excessive
food
consumption
and
sedentary
lifestyle,
has
focused
increasing
energy
expenditure.
Recently,
muscle
tissue
is
being
investigated
as
an
endocrine
active
organ,
secreting
molecules
called
myokines.
Multiple
studies
have
been
performed
to
assess
myokine
levels
in
various
disorders,
including
polycystic
ovary
syndrome
(PCOS)
metabolic
syndrome.
Irisin
Meteorin-like
protein
(Metrnl)
are
particles
which,
among
others,
suggested
play
important
role
adipose
browning
improving
insulin
sensitivity.
Material
methods:
The
study
population
consisted
of
31
women
with
PCOS
18
healthy
individuals.
was
diagnosed
based
revised
2003
Rotterdam
criteria.
anthropometrical,
hormonal,
biochemical
parameters
were
assessed,
oral
glucose
tolerance
test
body
composition
dual
X-ray
absorptiometry.
Serum
irisin
Metrnl
measured
by
enzyme-linked
immunosorbent
assay
(ELISA).
Results:
There
no
differences
between
the
control
groups
according
age,
mass
index
(BMI),
waist-to-hip
ratio
(WHR),
fasting
glucose,
homeostasis
model
assessment
resistance
(HOMA-IR),
or
composition.
Assessment
concentrations
revealed
significant
women.
level
negatively
correlated
BMI,
fat
mass,
concentrations.
No
relationship
found.
Conclusions:
Although
seems
be
a
promising
biomarker,
inconsistent
research
limits
its
value
clinical
use
treatment
obesity.
not
affected
population,
but
it
might
connected
severity
disturbances.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 17, 2025
Abstract
This
study
aimed
to
examine
the
potential
impacts
of
METRNL
as
an
antioxidant
and
anti-inflammatory
through
IκB
kinase/inhibitor
nuclear
factor-kappa
B/nuclear
factor-kappa-light-chain
signaling
pathway
on
many
biomarkers
lung
structure
in
rats
with
bronchial
asthma
induced
by
ovalbumin/lipopolysaccharide
(OVA/LPS).
Forty
were
randomly
divided
into
four
equal
groups:
control
group,
vehicle
diseased
(OVA/LPS)
group
OVA
2.5
ml/kg
intratracheal
installation/LPS
1.5
mg/kg
intraperitoneally,
treated
(OVA/LPS
+
METRNL)
at
a
dose
2
mg/rat/day
IV.
After
4
weeks,
plasma
tissues
analyzed
assess
oxidative
stress
inflammatory
markers.
Additionally,
histological
assessment
was
conducted
tissues.
Bronchial
confirmed
when
increased
levels
total
serum
IgE,
cell
count,
neutrophils,
eosinophils,
macrophages,
lymphocyte
counts
BAL
fluid
observed.
Moreover,
OVA/LPS
resulted
reduction
superoxide
dismutase
(SOD)
while
raising
malondialdehyde
(MDA).
Furthermore,
it
elevated
concentrations
mediators,
including
tumor
necrosis
factor-alpha
(TNF-alpha),
interleukin
17
(IL-17),
transforming
growth
factor
beta
(TGF-β).
The
protective
effects
analyzed.
observed
are
believed
result
from
drug’s
properties
its
action
IKK/IκB/NF-κB
pathway.
investigation
indicates
that
treatment
positively
improved
rats’
biochemical
aspects
OVA/LPS-induced
airway
allergic
inflammation.
Advances in Therapy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 19, 2025
Diabetes
mellitus
is
a
metabolic
disorder,
characterized
by
elevated
blood
sugar
levels
(hyperglycemia)
and
insulin
dysregulation.
This
disease
associated
with
morbidity
mortality,
including
significant
potential
vascular
complications.
High
of
hyperglycemia
lead
to
not
only
reactive
oxygen
species
but
also
advanced
glycation
end
products,
which
are
detrimental
the
endothelium
reduce
protective
compounds
such
as
nitric
oxide
prostacyclin.
damage
contributes
development
both
macrovascular
microvascular
The
present
investigation
explores
pathophysiological
mechanisms
diabetic
complications
evaluates
current
management
strategies,
lifestyle
modifications,
pharmacological
treatments,
emerging
therapies.
review
underscores
importance
ongoing
progress
in
diabetes
patient
education
optimal
patient-health
outcomes
quality
life
for
individuals
mellitus.
Archives of Physiology and Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 15
Published: April 27, 2025
Cardiovascular
diseases
(CVDs)
remain
a
leading
global
cause
of
mortality,
necessitating
non‑pharmacological
interventions
such
as
exercise.
Meteorin‑like
protein
(Metrnl),
an
exercise‑induced
myokine
and
adipokine,
has
emerged
critical
mediator
exercise‑mediated
cardiovascular
benefits,
though
its
specific
mechanisms
clinical
implications
underexplored.
This
review
synthesizes
current
evidence
on
Metrnl's
role
key
exerkine
in
health,
focusing
regulatory
mechanisms,
tissue‑specific
effects,
therapeutic
potential
for
CVD
management.
A
comprehensive
analysis
preclinical
studies
was
conducted,
encompassing
molecular,
metabolic,
anti‑inflammatory
pathways
linked
to
Metrnl.
Literature
from
PubMed,
Scopus,
Web
Science
systematically
reviewed
evaluate
adaptations.
Exercise‑induced
Metrnl
enhances
endothelial
function,
vascular
remodeling,
metabolic
regulation
via
AMPK,
PPARγ,
KIT
receptor
signaling.
It
promotes
glucose/lipid
metabolism,
angiogenesis,
responses,
reducing
atherosclerotic
risks
improving
cardiac
repair
post‑infarction.
Clinically,
levels
correlate
with
severity,
acting
biomarker
risk
stratification.
Acute
exercise
elevates
Metrnl,
while
chronic
training
effects
vary
by
modality
population.
Paradoxically,
elevated
plasma
acute
events
predicts
adverse
outcomes,
whereas
reduced
conditions
(e.g.,
diabetes,
heart
failure)
reflect
dysregulation.
bridges
benefits
health
through
inter‑organ
crosstalk,
yet
discrepancies
exist
regulation.
Its
dual
protective
stress‑responsive
underscores
context‑dependent
interpretations.
Unresolved
questions
include
specificity,
tissue
autonomy,
delivery
strategies.
is
pivotal
promising
diagnostic
CVDs.
Translating
into
applications
requires
further
human
trials
validate
optimize
interventions.
Harnessing
could
revolutionize
strategies
prevention
rehabilitation,
leveraging
exercise's
molecular
advantages.
The FASEB Journal,
Journal Year:
2024,
Volume and Issue:
38(24)
Published: Dec. 13, 2024
As
a
common
clinical
manifestation,
muscle
weakness
is
prevalent
in
people
with
mobility
disorders.
Further
studies
of
have
found
that
patients
present
persistent
inflammation,
loss
fibers,
fat
infiltration,
and
interstitial
fibrosis.
Therefore,
we
propose
the
concept
microenvironment
homeostasis,
which
explains
abnormal
pathological
changes
muscles
through
imbalance
homeostasis.
And
identified
an
progenitor
cell
FAP
during
transition
from
normal
homeostasis
to
caused
by
damage
diseases.
kind
pluripotent
stem
cell,
FAPs
do
not
participate
myogenic
differentiation,
but
can
differentiate
into
fibroblasts,
adipocytes,
osteoblasts,
chondrocytes.
mesenchymal
it
involved
generation
extracellular
matrix,
regulate
regeneration,
maintain
neuromuscular
junction.
However,
disrupted
causative
factors,
activities
eventually
contribute
complex
muscles.
Targeting
mechanisms
these
changes,
appropriate
signaling
targets
for
improve
even
treat
In
this
review,
construction
microenvironmental
find
key
cells
cause
after
broken.
By
studying
mechanism
differentiation
apoptosis
FAPs,
strategy
inhibit
diseases
regeneration.
Endokrynologia Polska,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 19, 2024
Introduction:
Research
on
obesity,
which
results
from
excessive
food
consumption
and
sedentary
lifestyle,
has
focused
increasing
energy
expenditure.
Recently,
muscle
tissue
is
being
investigated
as
an
endocrine
active
organ,
secreting
molecules
called
myokines.
Multiple
studies
have
been
performed
to
assess
myokine
levels
in
various
disorders,
including
polycystic
ovary
syndrome
(PCOS)
metabolic
syndrome.
Irisin
Meteorin-like
protein
(Metrnl)
are
particles
which,
among
others,
suggested
play
important
role
adipose
browning
improving
insulin
sensitivity.
Material
methods:
The
study
population
consisted
of
31
women
with
PCOS
18
healthy
individuals.
was
diagnosed
based
revised
2003
Rotterdam
criteria.
anthropometrical,
hormonal,
biochemical
parameters
were
assessed,
oral
glucose
tolerance
test
body
composition
dual
X-ray
absorptiometry.
Serum
irisin
Metrnl
measured
by
enzyme-linked
immunosorbent
assay
(ELISA).
Results:
There
no
differences
between
the
control
groups
according
age,
mass
index
(BMI),
waist-to-hip
ratio
(WHR),
fasting
glucose,
homeostasis
model
assessment
resistance
(HOMA-IR),
or
composition.
Assessment
concentrations
revealed
significant
women.
level
negatively
correlated
BMI,
fat
mass,
concentrations.
No
relationship
found.
Conclusions:
Although
seems
be
a
promising
biomarker,
inconsistent
research
limits
its
value
clinical
use
treatment
obesity.
not
affected
population,
but
it
might
connected
severity
disturbances.